Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02781883
Title Clinical Trial of BP1001 (Liposomal Grb2 Antisense Oligonucleotide) in Combination With LDAC in Patients With Previously Untreated AML
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bio-Path Holdings, Inc.

acute myeloid leukemia


BP1001 + Cytarabine

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.